NIH-funded research NIH-funded research

Investigating how a specific protein affects bone loss as we age

Official title: Role of Hypoxia-inducible factor-2α signaling in age-induced bone loss

Funded at University of California at Davis · NIH-11037775 · Data updated 2026-11-12

This study is looking at how a specific protein called HIF-2α affects bone loss as we age, with the goal of finding new ways to help older adults keep their bones strong and healthy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California at Davis
NIH-funded
Lab location1 site (Davis, United States)
Project startDecember 15, 2024
Project endNovember 30, 2025
Funding year2025
Award (this year)$55,496
NIH project number1R36AG090801-01
Project IDNIH-11037775 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing or at risk of osteoporosis and related bone health issues.

Less likely to help

Patients who are younger than 21 or those without age-related bone loss may not benefit from this research.

What this research studies

This research explores the role of hypoxia-inducible factor-2α (HIF-2α) in the process of bone loss associated with aging. It aims to identify the mechanisms that lead to osteoporosis, a condition where bones become weak and brittle, particularly in older adults. By understanding how HIF-2α signaling changes with age, the researchers hope to develop new therapies that can reverse bone loss and improve overall bone health. The study will involve examining the cellular processes that contribute to bone deterioration and how they can be targeted for treatment.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or reverse age-related bone loss, improving quality of life for older adults.

How similar studies have gone: Previous research has shown promising results in targeting similar pathways for improving bone health, indicating potential for success in this approach.

Where this research is happening

  • University of California at Davis
    Davis, United States
    Active

Researchers

  • Principal investigator: Mendoza, Sarah Vanessa — University of California at Davis
  • Study coordinator: Mendoza, Sarah Vanessa

Related research

Other NIH-funded projects on the same topics.

  • Using MRI to measure brain oxygen levels as an early sign of small vessel disease in the brain

    This study is looking at how measuring oxygen levels in the brain with MRI can help spot early signs of small vessel disease, which is linked to memory problems and dementia, especially Alzheimer's, so if you're at risk due to age or high blood pressure, you might be able to participate in MRI scans to learn more about

    NIH research Washington University · Saint Louis, United States · NIH-9960958

  • How HIV and HIV meds affect jaw bone and teeth

    This project looks at how HIV, its treatment, and immune changes may cause jawbone and tooth loss in people living with HIV.

    NIH research Emory University · Atlanta, United States · NIH-11596027

  • Periodontitis and HIV treatment–related bone loss in the jaw and teeth

    This project studies how HIV and its treatment affect jawbone and tooth loss in people living with HIV, aiming to understand and reduce bone damage around teeth.

    NIH research Emory University · Atlanta, United States · NIH-11596026

  • HIF-driven ways to repair damaged lungs in IPF

    A doctor-researcher is testing how low-oxygen signals (HIF) could help restore healthy lung tissue in people with IPF.

    NIH research University of Colorado Denver · Aurora, UNITED STATES · NIH-11577275

  • Neonatal Brain Injury Protection with New Purine Compounds

    A new medication approach using purine derivatives is being studied to protect newborn brains from injury caused by limited blood flow and oxygen during birth.

    NIH research Women and Infants Hospital-Rhode Island · Providence, United States · NIH-11541249

  • Aldo-keto reductase (AKR) helps brain BH4 levels after injury

    This grant tests whether brain AKR enzymes can boost BH4 levels and support better brain function after hypoxia-ischemia-related injury.

    NIH research Medical College of Wisconsin · Milwaukee, United States · NIH-11447154

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.